These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11829133)

  • 21. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    van Gerven JM; Roncari G; Schoemaker RC; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen AF; Dingemanse J
    Br J Clin Pharmacol; 1997 Nov; 44(5):487-93. PubMed ID: 9384466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
    Hering W; Ihmsen H; Albrecht S; Schwilden H; Schüttler J
    Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.
    Cox EH; Van Hemert JG; Tukker EJ; Danhof M
    J Pharmacol Toxicol Methods; 1997 Oct; 38(2):99-108. PubMed ID: 9403781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam.
    Bauer LO; Gross JB; Meyer RE; Greenblatt DJ
    Psychopharmacology (Berl); 1997 Oct; 133(3):293-9. PubMed ID: 9361336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
    Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
    Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy.
    Cleton A; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal.
    Schnider TW; Minto CF; Fiset P; Gregg KM; Shafer SL
    Anesthesiology; 1996 Mar; 84(3):510-9. PubMed ID: 8659777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-injection delays in experimental chambers, but not in home cages, produce both sensitization and tolerance of operant behaviour to midazolam: relation to pharmacokinetics.
    Sun L; Falk JL; Nguyen KN; Lau CE
    Behav Pharmacol; 2000 Apr; 11(2):133-42. PubMed ID: 10877118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system.
    Koopmans R; Dingemanse J; Danhof M; Horsten GP; van Boxtel CJ
    Clin Pharmacol Ther; 1988 Jul; 44(1):14-22. PubMed ID: 3391000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo.
    Hoyo-Vadillo C; Mandema JW; Danhof M
    Life Sci; 1995; 57(4):325-33. PubMed ID: 7603305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
    Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
    Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam.
    Bührer M; Maitre PO; Crevoisier C; Stanski DR
    Clin Pharmacol Ther; 1990 Nov; 48(5):555-67. PubMed ID: 2225714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
    Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat.
    Bol CJ; Vogelaar JP; Tang JP; Mandema JW
    J Pharmacol Exp Ther; 2000 Jul; 294(1):347-55. PubMed ID: 10871332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.